Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and...

Leukemia 2017 / 4 Vol. 31; Iss. 4

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Ludwig, H, Weisel, K, Petrucci, M T, Leleu, X, Cafro, A M, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauléon, S, Dümmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2017.5
Date:
April, 2017
File:
PDF, 931 KB
english, 2017
Conversion to is in progress
Conversion to is failed